Bryt A B, Rogers D E
Cornell University Medical College, New York, NY 10021.
Bull N Y Acad Med. 1994 Summer;71(1):18-36.
Tuberculosis, once on the steady decline in the western world, has resurfaced with renewed vigor in the wake of the human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) epidemic. People with HIV infection are both more likely to contract primary tuberculosis and at greater risk for reactivation of latent tuberculosis. Tuberculous disease may present with atypical signs and symptoms in HIV-infected hosts because of alterations in the immune system. Superimposed on the virulent interaction of HIV and tuberculosis is the emerging problem of multidrug resistant strains that often resist currently available therapies. HIV-positive health professionals working in high-risk environments pose a special problem, while populations unable to comply with currently available pharmacological therapies pose another. We have many tools available to combat the resurgence of tuberculosis, but new methods of diagnosis and new approaches to treatment are sorely needed.
结核病在西方世界曾一度呈稳步下降趋势,但在人类免疫缺陷病毒(HIV)/获得性免疫缺陷综合征(AIDS)流行之后,又以新的活力再度出现。感染HIV的人感染原发性结核病的可能性更大,潜伏性结核病重新激活的风险也更高。由于免疫系统发生改变,结核病在感染HIV的宿主中可能表现出非典型的体征和症状。除了HIV与结核病的致命相互作用之外,多重耐药菌株这一新兴问题也常常使目前可用的治疗方法失效。在高风险环境中工作的HIV阳性医护人员带来了一个特殊问题,而无法遵守目前可用药物治疗的人群则带来了另一个问题。我们有许多工具可用于抗击结核病的死灰复燃,但迫切需要新的诊断方法和新的治疗方法。